Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Alemtuzumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alemtuzumab 12mg/1.2ml solution for infusion vials
0802030E0AAABAB
|
Alemtuzumab | Alemtuzumab | Malignant Disease and Immunosuppression | No data available |
|
Alemtuzumab 30mg/1ml solution for infusion vials
0802030E0AAAAAA
|
Alemtuzumab | Alemtuzumab | Malignant Disease and Immunosuppression | No data available |
|
Lemtrada 12mg/1.2ml concentrate for inf vials
0802030E0BCAAAB
|
Lemtrada | Alemtuzumab | Malignant Disease and Immunosuppression | No data available |
|
MabCampath 30mg/1ml concentrate for inf vials
0802030E0BBAAAA
|
MabCampath | Alemtuzumab | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.